Heinz Schneider

Summary

Affiliation: HealthEcon AG
Country: Switzerland

Publications

  1. pmc A German national prevalence study on the cost of intensive care: an evaluation from 51 intensive care units
    Onnen Moerer
    Department of Anaesthesiology, Emergency and Critical Care Medicine, University of Gottingen, Robert Koch Strasse 40, Gottingen 37075, Germany
    Crit Care 11:R69. 2007
  2. pmc PORTAL: pilot study on the safety and tolerance of preoperative melatonin application in patients undergoing major liver resection: a double-blind randomized placebo-controlled trial
    Peter Schemmer
    Department of General Surgery, Ruprecht Karls University, Heidelberg, Germany
    BMC Surg 8:2. 2008
  3. pmc Trends and stabilization up to 2022 in overweight and obesity in Switzerland, comparison to France, UK, US and Australia
    Heinz Schneider
    HealthEcon AG, CH 4001 Basel, Switzerland
    Int J Environ Res Public Health 7:460-72. 2010
  4. ncbi Modelling the lifetime costs and health effects of lifestyle intervention in the prevention and treatment of obesity in Switzerland
    Carmen Galani
    HealthEcon AG, Basel, Switzerland
    Int J Public Health 52:372-82. 2007
  5. ncbi Economic burden of obesity and its comorbidities in Switzerland
    Alexandra Schmid
    HealthEcon AG, Basel, Switzerland
    Soz Praventivmed 50:87-94. 2005
  6. ncbi Prevention and treatment of obesity with lifestyle interventions: review and meta-analysis
    Carmen Galani
    HealthEcon AG, Basel, Switzerland
    Int J Public Health 52:348-59. 2007
  7. doi Uncertainty in decision-making: value of additional information in the cost-effectiveness of lifestyle intervention in overweight and obese people
    Carmen Galani
    HealthEcon AG, Basel, Switzerland
    Value Health 11:424-34. 2008
  8. ncbi Obesity and its comorbidities: present and future importance on health status in Switzerland
    Aileen Neilson
    HealthEcon AG, Basel, Switzerland
    Soz Praventivmed 50:78-86. 2005

Collaborators

  • Carmen Galani
  • Ulrich Keller
  • Alain Golay
  • Alexandra Schmid
  • Peter Schemmer
  • Onnen Moerer
  • Aileen Neilson
  • Arash Nickkholgh
  • Markus Weigand
  • Markus W Buchler
  • Jurgen Weitz
  • Moritz Koch
  • Michael Sobirey
  • Enno Plock
  • Manfred Bernd Wischnewsky
  • Hilmar Burchardi
  • Uchenna Mgbor

Detail Information

Publications8

  1. pmc A German national prevalence study on the cost of intensive care: an evaluation from 51 intensive care units
    Onnen Moerer
    Department of Anaesthesiology, Emergency and Critical Care Medicine, University of Gottingen, Robert Koch Strasse 40, Gottingen 37075, Germany
    Crit Care 11:R69. 2007
    ..Intensive care unit (ICU) costs account for up to 20% of a hospital's costs. We aimed to analyse the individual patient-related cost of intensive care at various hospital levels and for different groups of disease...
  2. pmc PORTAL: pilot study on the safety and tolerance of preoperative melatonin application in patients undergoing major liver resection: a double-blind randomized placebo-controlled trial
    Peter Schemmer
    Department of General Surgery, Ruprecht Karls University, Heidelberg, Germany
    BMC Surg 8:2. 2008
    ..Experimental data suggest that preoperative supraphysiological doses of melatonin, a potent immuno-modulator and antioxidant, would decrease postoperative infectious and non-infectious complications induced by major abdominal surgery...
  3. pmc Trends and stabilization up to 2022 in overweight and obesity in Switzerland, comparison to France, UK, US and Australia
    Heinz Schneider
    HealthEcon AG, CH 4001 Basel, Switzerland
    Int J Environ Res Public Health 7:460-72. 2010
    ..Based on the projection, these prevalence rates may be expected to stabilize until 2022 at the 2007 level. These results were compared with future projections estimated for France, UK, US and Australia using the same model...
  4. ncbi Modelling the lifetime costs and health effects of lifestyle intervention in the prevention and treatment of obesity in Switzerland
    Carmen Galani
    HealthEcon AG, Basel, Switzerland
    Int J Public Health 52:372-82. 2007
    ..To quantify the lifetime health and economic consequences of preventing and treating obesity with lifestyle intervention in Switzerland...
  5. ncbi Economic burden of obesity and its comorbidities in Switzerland
    Alexandra Schmid
    HealthEcon AG, Basel, Switzerland
    Soz Praventivmed 50:87-94. 2005
    ..To estimate the total annual economic costs caused by overweight and obesity in Switzerland...
  6. ncbi Prevention and treatment of obesity with lifestyle interventions: review and meta-analysis
    Carmen Galani
    HealthEcon AG, Basel, Switzerland
    Int J Public Health 52:348-59. 2007
    ..To assess the mid- to long-term effectiveness of lifestyle interventions in the prevention and treatment of obesity...
  7. doi Uncertainty in decision-making: value of additional information in the cost-effectiveness of lifestyle intervention in overweight and obese people
    Carmen Galani
    HealthEcon AG, Basel, Switzerland
    Value Health 11:424-34. 2008
    ..There has been an increasing interest in using value of information analysis in medical decision-making to quantify the uncertainty in decision-making, and to identify the need for further research...
  8. ncbi Obesity and its comorbidities: present and future importance on health status in Switzerland
    Aileen Neilson
    HealthEcon AG, Basel, Switzerland
    Soz Praventivmed 50:78-86. 2005
    ..The objective of this study was to estimate the proportion of various diseases attributable to obesity in Switzerland in order to get a hint of its present and future importance on health status and on our health care budgets...